Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Bill Haddad

1664 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • News
  • Offerings

Medicenna Prices 3,333,334 Unit Offering At $1.50/Unit

By Bill Haddad
August 9, 9:16 AM
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (NASDAQ:MDNA, TSX:MDNA), a clinical stage immunotherapy company, announced today that it has priced its previously-announced marketedMedicenna Therapeutics Corp.

MDNA

Read More
2 minute read
  • Biotech
  • General

Veru Highlights Presentation Of Phase 3 Study Of Sabizabulin At 11th International Conference on Emerging Infectious Diseases (ICEID) On August 7-10

By Bill Haddad
August 9, 8:33 AM
Veru Inc. (NASDAQ:VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers, today announced

VERU

Read More
1 minute read
  • Earnings
  • News

Gilat Satellite Networks Q2 Sales $55.50M Miss $56.24M Estimate

By Bill Haddad
August 9, 7:53 AM
Gilat Satellite Networks (NASDAQ:GILT) reported quarterly sales of $55.50 million which missed the analyst consensus estimate of $56.24 million by 1.32 percent. This is a 2.50 percent decrease over sales of $56.92

GILT

Read More
1 minute read
  • Earnings
  • News

Whole Earth Brands Q2 EPS $0.03 Misses $0.10 Estimate, Sales $133.50M Beat $130.91M Estimate

By Bill Haddad
August 9, 7:39 AM
Whole Earth Brands (NASDAQ:FREE) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.10 by 70 percent. This is a 66.67 percent decrease over earnings of $0.09 per share from

FREE

Read More
1 minute read
  • Earnings
  • News

Broadwind Energy Q2 EPS $(0.13) Misses $(0.11) Estimate, Sales $50.00M Beat $43.28M Estimate

By Bill Haddad
August 9, 7:15 AM
Broadwind Energy (NASDAQ:BWEN) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 124.53 percent decrease over earnings of $0.53 per share

BWEN

Read More
2 minute read
  • Cryptocurrency
  • Markets

CleanSpark Acquires An Active Bitcoin Mining Facility In Washington, Georgia, For $16.2M

By Bill Haddad
August 9, 7:11 AM
 CleanSpark, Inc. (NASDAQ:CLSK) (the "Company"), America's Bitcoin Miner™, today announced it has entered into a definitive agreement to acquire an active bitcoin mining facility located in

CLSK

Read More
1 minute read
  • Earnings
  • News

Bentley Systems Q2 Adj. EPS $0.22 Beats $0.18 Estimate, Sales $268.30M Beat $267.77M Estimate

By Bill Haddad
August 9, 7:07 AM
Bentley Systems (NASDAQ:BSY) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.18 by 22.22 percent. This is a 4.35 percent decrease over earnings of $0.23 per share from the

BSY

Read More
1 minute read
  • Guidance
  • News

AdaptHealth Maintains FY22 Guidance

By Bill Haddad
August 9, 7:05 AM
Guidance Maintained for Fiscal Year 2022 The Company is maintaining its previously issued financial guidance for fiscal year 2022, as follows: Net revenue of $2.840 billion to $3.040

AHCO

Read More
1 minute read
  • Earnings
  • News

Bausch Health Companies Q2 Sales $1.97B Miss $2.61B Estimate

By Bill Haddad
August 9, 7:01 AM
Bausch Health Companies (NYSE:BHC) reported quarterly sales of $1.97 billion which missed the analyst consensus estimate of $2.61 billion by 24.64 percent. This is a 6.33 percent decrease over sales of $2.10 billion the

BHC

Read More
1 minute read
  • Earnings
  • News

Emerson Electric Q3 EPS $1.38 Beats $1.30 Estimate, Sales $5.00B Miss $5.12B Estimate

By Bill Haddad
August 9, 6:59 AM
Emerson Electric (NYSE:EMR) reported quarterly earnings of $1.38 per share which beat the analyst consensus estimate of $1.30 by 6.15 percent. This is a 26.61 percent increase over earnings of $1.09 per share from the

EMR

Posts pagination

Previous 1 … 111 112 113 … 167 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service